TAISHO PHARMACEUTICAL HOLDINGS CO.,LTD. 4581Short Interest
No institution currently reports a short position of 0.5% or more in TAISHO PHARMACEUTICAL HOLDINGS CO.,LTD. (4581). The last disclosure was on 2022-05-31 (Integrated Core Strategies (Asia) Pte. Ltd., 0.08%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
18 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 1 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2022-02-02 |
|---|---|
| Latest disclosure | 2022-05-31 (Integrated Core Strategies (Asia) Pte. Ltd., 0.08%) |
| Reporting institutions | 1 firms (18 reports) |
| Peak estimated short interest | 1.45% (2022-05-27, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 1 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2022-05-31 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 68,700 shares | Ratio 0.08% | ▼1.19% | Below 0.5% |
Disclosure History 18 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2022-05-31 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 68,700 shares | Ratio 0.08% | ▼1.19% | Below 0.5% |
| 2022-05-30 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 1,082,300 shares | Ratio 1.27% | ▼0.18% | — |
| 2022-05-27 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 1,240,500 shares | Ratio 1.45% | ▲0.10% | — |
| 2022-05-26 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 1,149,900 shares | Ratio 1.35% | ▲0.09% | — |
| 2022-05-25 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 1,078,200 shares | Ratio 1.26% | ▲0.15% | — |
| 2022-05-23 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 950,100 shares | Ratio 1.11% | ▲0.10% | — |
| 2022-05-19 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 866,100 shares | Ratio 1.01% | ▲0.10% | — |
| 2022-05-17 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 778,600 shares | Ratio 0.91% | ▲0.08% | — |
| 2022-05-11 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 713,700 shares | Ratio 0.83% | ▲0.13% | — |
| 2022-05-06 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 596,000 shares | Ratio 0.70% | ▲0.09% | — |
| 2022-05-02 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 525,400 shares | Ratio 0.61% | ▲0.03% | — |
| 2022-04-27 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 494,600 shares | Ratio 0.58% | ▼0.10% | — |
| 2022-04-25 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 583,600 shares | Ratio 0.68% | ▼0.03% | — |
| 2022-04-20 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 605,500 shares | Ratio 0.71% | ▲0.09% | — |
| 2022-04-14 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 529,400 shares | Ratio 0.62% | ▲0.12% | — |
| 2022-04-12 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 431,500 shares | Ratio 0.50% | ▲0.08% | — |
| 2022-02-10 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 415,400 shares | Ratio 0.48% | ▼0.04% | Below 0.5% |
| 2022-02-02 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 443,500 shares | Ratio 0.52% | ▲0.09% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| CanBas Co.,Ltd.4575 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| D.Western Therapeutics Institute, Inc.4576 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Daito Pharmaceutical Co.,Ltd.4577 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| Otsuka Holdings Co.,Ltd.4578 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |